A. M. Abd El-Aty, Cairo University, Egypt
Featured editorial: Methodological challenges in studies of the role of blood lipids variability in the incidence of cardiovascular disease
We are proud to publish a new editorial by Associate Editor Leonelo E. Bautista and Oscar L. Rueda-Ochoa. It has long been known that high levels of total and LDL-cholesterol, and low levels of HDL increase the risk of developing atherosclerotic cardiovascular diseases. Recent studies suggest that high intra-individual variability in blood lipids may increase the risk of major cardiovascular events, independently of individual average levels. Here we discuss some methodological challenges in studies of the causal effect of blood lipids variability (BLV) on the risk of MACE, and suggest possible solutions.
Featured series: Metabolic regulation of lipids and fatty acids and risk of cardiometabolic disease
We are proud to announce a new thematic series, guest edited by Vibeke Telle-Hansen. This collection of papers addresses the role of lipids and lipid metabolism in cancer. We warmly welcome all articles and reviews on solid and non-solid tumors. We aim to include original research and up-to-date reviews on individual regulation of lipids and fatty acids, in relation to different risk profiles (metabotypes) of cardiometabolic disease. You can read more about the scope, here.
Featured series: Sphingomyelin- Key Roles in Health and Disease
We are proud to announce a new thematic series, guest edited by Rashika El Ridi and Junfei Jin. We wish to welcome articles, including original research, narrative reviews, systematic reviews and meta-analysis, and mini-reviews which establish the relation between sphingomyelin metabolism and cancer immune evasion, thus allowing the discovery of unprecedented approaches and new molecules for cancer prevention and therapy. Find out more about the scope here.
Featured series: Role of lipids and lipid metabolism in cancer
We are proud to announce a new thematic series, guest edited by Christa Buechler. This collection of papers in this addresses the role of lipids and lipid metabolism in cancer. There is emerging evidence that lipids and lipid metabolism are essential for cancer growth. The identification of suitable serum lipid biomarkers as diagnostic tools is in the focus of current research. Lipid metabolism may also become a target for cancer therapy. We warmly welcome all articles and reviews on solid and non-solid tumors.. Find out more about the scope here.
Please check out the LHAD articles with the highest Altmetric scores, since our journal launched in 2002. Altmetric calculates a score based on the online attention an article receives. Social media and mainstream news media are the main sources that calculate the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Have a submission you want to make sure is right for Lipids in Health and Disease? Or a great idea for a new submission or thematic series? Tell our Editor-in-Chief, A. M. Abd El-Aty!
Aims and scope
Lipids in Health and Disease is an open access, peer-reviewed, journal that publishes articles on all aspects of lipids: their biochemistry, pharmacology, toxicology, role in health and disease, and the synthesis of new lipid compounds.
Lipids in Health and Disease is aimed at all scientists, health professionals and physicians interested in the area of lipids. Lipids are defined here in their broadest sense, to include: cholesterol, essential fatty acids, saturated fatty acids, phospholipids, inositol lipids, second messenger lipids, enzymes and synthetic machinery that is involved in the metabolism of various lipids in the cells and tissues, and also various aspects of lipid transport, etc. In addition, the journal also publishes research that investigates and defines the role of lipids in various physiological processes, pathology and disease. In particular, the journal aims to bridge the gap between the bench and the clinic by publishing articles that are particularly relevant to human diseases and the role of lipids in the management of various diseases.
Make a suggestion here
Reviewers of the quarter
Lipids in Health and Disease is pleased to implement a new platform of recognition every quarter, for the peer reviewers who provided the best performance along the parameters of acceptance rate, scrutiny of the reviews, completion, accepted-completion %, On time delivery-Completion %, and our Editor-in-Chief's evaluation rate. Please click here, to learn about our Reviewers of the Quarter.
Annual Journal Metrics
60 days to first decision for reviewed manuscripts only
39 days to first decision for all manuscripts
139 days from submission to acceptance
16 days from acceptance to publication
629 Altmetric Mentions